Shopping Cart
- Remove All
- Your shopping cart is currently empty
Gavilimomab (ABX-CBL), an IgM murine monoclonal antibody, targets CD147 on cell surfaces to induce complement-mediated cytotoxicity. It is utilized in the study of graft-versus-host disease (GVHD) [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $1,089 | 4-6 weeks | |
5 mg | $2,389 | 4-6 weeks | |
10 mg | $3,578 | 4-6 weeks |
Description | Gavilimomab (ABX-CBL), an IgM murine monoclonal antibody, targets CD147 on cell surfaces to induce complement-mediated cytotoxicity. It is utilized in the study of graft-versus-host disease (GVHD) [1]. |
Alias | ABX-CBL |
Cas No. | 244096-20-6 |
Storage | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.